# The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma

> **NCT04100902** · PHASE4 · COMPLETED · sponsor: **Bispebjerg Hospital** · enrollment: 39 (actual)

## Conditions studied

- Allergic Asthma Due to Dermatophagoides Pteronyssinus

## Interventions

- **DRUG:** ODACTRA 12 SQ-HDM Sublingual Tablet
- **DRUG:** Placebo sublingual tablet

## Key facts

- **NCT ID:** NCT04100902
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-20
- **Primary completion:** 2022-02-27
- **Final completion:** 2022-02-27
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04100902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04100902, "The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04100902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*